Association of paraoxonase 55 and 192 gene polymorphisms on serum homocysteine concentrations in preeclampsia

Folia Biologica

Volumn 55, Issue 2, 2009, Pages 35-40

  Isbilen, E ^a   Yilmaz, H ^b   Arzu Ergen, H ^b   Unlucerci, Y ^c   Isbir, Turgay ^b   Gurdol, F ^c  

^a BASKENT UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Genetic polymorphism; Homocysteine; Paraoxonase; Preeclampsia

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANT WOMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

EID: 65549105968     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Adkins, S., Gan, K. N., Mody, M., La Du, B. N. (1993) Molecular basis for the polymorphic forrns of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet. 52, 598-608.
2. Agaçhan, B., Yilmaz, H., Karaali, Z., Isbir, T. (2004) Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus. Cell Biochem. Funct. 22, 163-168.
3. Agaçhan, B., Yilmaz, H., Ergen, H. A., Karaali, Z. E., Isbir, T. (2005) Paraoxonase (PONI) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in Turkish patients with type 2 diabetes mellitus. Physiol. Res. 54, 287-293.
4. Antikainen, M., Murtomaki, S., Syvanne, M., Pahlman, R., Tahvanainen, E., Jauhiainen, M., Frick, M. H., Ehnholm, C. (1996) The GInArg 191 polymorphism. of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J. Clin. Invest. 98, 883-885.
5. Bilge, I., Sirin, A., Agaghan, B., Emre, S., Sadikoglu, B., Yilmaz, H., Sucu, A., Isbir, T. (2007) Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children? Cell Biochem. Funct. 25, 159-165.
6. Braekke, K., Ueland, P. M., Harsem, N. K., Karlsen, A., Blomhoff, R., Staff, A. C. (2007) Homocysteine, cysteine, and related metabolites in maternal and fetal plasma in preeclampsia. Pediatr Res. 62, 319-324.
7. Dekker, G. A., van Geijn, H. P. (1996) Endothelial dysfunction in preeclampsia. Part II. Reducingthe adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives. J. Perinat. Med. 24, 119-139.
8. Eckerson, H. W., Wyte, C. M., La Du, B. N. (1983) The human serum paraoxonase/arylesterase polymorphism. Identification of phenotypes by their response to salts. Am. J. Hum. Genet. 35, 214-227.
9. Gardemann, A., Philipp, M., Hess, K., Katz, N., Tillmanns, H., Haberbosch, W. (2000) The paraoxonase LeuMct54 and GInArg191 gene polymorphisms are not associated with the risk of coronary heart disease. Atherosclerosis 152, 421-431.
10. Gratacos, E., Casals, E., Deulofeu, R., Cararach, V., Alonso, P. L., Fortuny, A. (1998) Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy. Am. J. Obstet. Gynecol. 178, 1072-1076.
11. Gratacos, E. (2000) Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 92, 63-66.
12. Herrmann, S. M., Blanc, H., Poirier, O., Arveiter, D., Luc, G., Evans, A., Marques-Vidal, P., Bard, J. M., Cambien, F. (1996) The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study. Atherosclerosis 126, 299-304.
13. Holmes, V A., Wallace, J. M., Alexander, H. D., Gilmore, W. S., Bradbury, I., Ward, M., Scott, J. M., Mcfaul, P., McNulty, H. (2005) Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation. Clin. Chem. 51, 629-634.
14. Hubel, C. A. (1999) Oxidative stress in the pathogenesis of preeclampsia. Proc. Soc. Exp. Biol. Med. 222, 222-235.
15. Humbert, R., Adler, D. A., Disteche, C. M., Hassett, C., Omiecinski, C. J., Furlong, C. E. (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3, 73-76.
16. Jakubowski, H., Ambrosius, W. T., Pratt, H. (2001) Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis. FEBS Lett. 491, 35-39.
17. Jakubowski, H. (2002) Hornocysteine is a protein amino acid in humans: Implications for homocysteine-linked disease. J Biol. Chem. 277, 30425-30428.
18. Kim, Y. J., Park, H. S., Park, M. H., Suh, S. H., Pang, M., G. (2005) Oxidative stress-related gene polymorphism and the risk of preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 119, 42-46.
19. Kumru, S., Aydin, S., Gursu, M. F., Ozcan, Z. (2004) Changes of serum paraoxonase (an HDL cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women. Eur. J. Obstet. Gynecol. Reprod. Biol. 114, 177-181.
20. Lacinski, M., Skorupski, W., Cieslinski, A., Sokolowska, J., Trzeciak, W. H., Jakubowski, H. (2004) Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans. Cell Mol. Biol. 50, 885-893.
21. Lawlor, D. A., Gaunt, T. R., Hinks, L. J., Smith, G. D., Timpson, N., Day, I. A., M., Ebrahim, S. (2006) The association of the PON1 Q192R polymorphism with complications and outcomes of pregnancy: findings from the British Women's Heart and Health cohort study. Paediatr. Perinat. Epidemiol. 20, 244-250.
22. Mackness, B., Durrington, P. N., Mackness, M. I. (1998) Human serum paraoxonase. Gen. Pharmac. 31, 329-336.
23. Mignini, L. E., Latthe, P. M., Villar, J., Kilby, M. D., Carroli, G., Khan, K. S. (2005) Mapping the theories of preeclampsia: the role of homocysteine. Obstet. Gynecol. 105, 411-425.
24. Miller, S. A., Dykes, D. D., Polesky, H. S. (1998) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16, 1215.
25. Noris, M., Perico, N., Remuzzi, G. (2005) Mechanisms of disease: preeclampsia. Nat. Clin. Pract. Nephrol. 1, 98-114.
26. Roberts, J. M., Gammill, H. S. (2005) Preeclampsia: recent insights. Hypertension 46, 1243-1249.
27. Sarandol, E., Safak, O., Dirican, M., Uncu, G. (2004) Oxidizability of apolipoprotein B containing lipoproteins and serum paraoxonase/ arylesterase activities in preeclampsia. Clin. Biochem. 37, 990-996.
28. Schmidt, H., Schmidt, R., Niederkom, K., Gradert, A., Schumacher, M., Watzinger, N., Hartung, H. P., Kostner, G. M. (1998) Paraoxonase PONI polymorphism LeuMet54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Stroke 29, 2043-2048.
29. Serrato, M., Marian, A. L. (1995) A variant of human paraoxonase/ arylesterase (HUMPONA) gene is a risk factor for coronary heart disease. J. Clin. Invest. 96, 3005-3008.
30. Ubbink, J. B., Vermaak, W. H. J., Bissbort, S. (1991) Rapid high perfon-nance liquid chromatographic assay for total homocysteine levels in human serum. J. Chromatogr. 565, 441-446.
31. Uzun, H., Benian, A., Madazli, R., Topcuoglu, M. A., Aydin, S., Albayrak, M. (2005) Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol. Obstet. Invest. 60, 195-200.
32. Yilmaz, H., Unlucerci, Y, Gurdol, R, Isbilen, E., Isbir, T. (2004) Association of pre-eclampsia with hyperhomocysteinaemia and methylene-tetrahydrofolate reductase gene C677T polymorphism in a Turkish population. Aust. N. Z J. Obstet. Gynaecol. 44, 423-427.